机译:Bak的MCL-1和BCL-X L螯合赋予差异抗性抗性抗性蛋白质。
The Walter and Eliza Hall Institute of Medical Research Parkville VIC;
The Walter and Eliza Hall Institute of Medical Research Parkville VIC;
The Walter and Eliza Hall Institute of Medical Research Parkville VIC;
Olivia Newton-John Cancer Research Institute Heidelberg VIC;
Olivia Newton-John Cancer Research Institute Heidelberg VIC;
The Walter and Eliza Hall Institute of Medical Research Parkville VIC;
The Walter and Eliza Hall Institute of Medical Research Parkville VIC 3052 Australia.;
机译:Bak的MCL-1和BCL-X L螯合赋予差异抗性抗性抗性蛋白质。
机译:在非转化细胞中,Bak会在抗凋亡Bcl-X L sub>和Mcl-1丢失后激活,但在缺少仅BH3活性蛋白的情况下
机译:内源性Bak抑制剂Mcl-1和Bcl-xL:对Bax缺陷癌对TRAIL耐药性的差异影响
机译:癌症相关的成纤维细胞(CAF)赋予循环肿瘤细胞抗剪力
机译:Bcl-x和Mcl-1前mRNA剪接使用剪接转换寡核苷酸的修饰。
机译:Bak的Mcl-1和Bcl-xL螯合赋予仅BH3蛋白不同的抗性
机译:Bak的MCL-1和BCL-XL封存赋予差异耐受BH3蛋白质